Roger Highfield, Science Director, discusses two new COVID-19 vaccines under development, one of which is manufactured by cells from the fall armyworm moth, with Dr Ian Gray, Medical Director of Sanofi UK and Ireland.
How do you ensure that ‘COVID-19 jabs are in arms, not fridges’? Roger Highfield, Science Director, talks to Dr Emily Lawson, England’s vaccine deployment lead in the National Health Service.
How do you know which vaccine research to back when a pandemic starts? Roger Highfield, Science Director, talks to Kate Bingham, former chair of the UK Government’s Vaccine Taskforce.
A traditional kind of vaccine is being readied for the fight against the COVID-19 pandemic. Roger Highfield, Science Director, finds out about Europe’s first ‘inactivated virus’ vaccine.
Roger Highfield, Science Director, talks to the scientist behind the world’s first COVID-19 vaccine that requires only a single dose.
In celebration of the International Day of Women and Girls in Science on 11 February, Science Museum Group’s Director of Learning Susan Raikes outlines the importance of encouraging women and girls into careers in STEM (Science, Technology, Engineering, Maths) and highlights some of the many roles available.
For the first time, scientists can see a pandemic evolve in real time at the genetic level, revealing ‘variants of concern’ while guarding for large-scale genetic changes in COVID-19 that might occur by a process called recombination.
Mutant versions of the SARS-CoV-2 virus have set off alarms worldwide. Science Director Roger Highfield talks to one of the laboratories racing to find out what these variants mean for COVID-19 transmissibility and virulence, along with the development of drugs and vaccines.
The pandemic has led to the steepest slowdown in human activity since the Second World War. Science Director, Roger Highfield, asks what this means for climate change.
The UK is the first country in the world to give temporary authorisation to the Pfizer/BioNTech coronavirus vaccine for emergency pandemic use.
This is a new kind of vaccine, based on RNA, and the first approved for use in humans. Roger Highfield, Science Director, talks to Dr Berkeley Phillips, UK Medical Director of Pfizer.